Newsfiscal.ai
Vanda Pharmaceuticals Reports Third Quarter 2026 Financial Results
· Published
Article summary
Vanda Pharmaceuticals announced its financial results for the third quarter ended September 30, 2026, reporting total revenues of $69.8 million and updating its full-year 2026 revenue guidance.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…